| Serial Number | 97928862 |
| Word Mark | CYTOTIL |
| Filing Date | Wednesday, May 10, 2023 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Thursday, November 21, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | custom manufacture of cells for medical or clinical use for others; custom manufacture of pharmaceutical preparations for others in the fields of cell therapy, gene therapy, regenerative medicine and biopharmaceuticals; custom manufacture of biological preparations for others for the treatment of cancer |
| Goods and Services | medical and scientific research and development services in the fields of cell therapy, gene therapy, oncology, and immunotherapy |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 8, 2023 |
| Primary Code | 040 |
| First Use Anywhere Date | Monday, September 30, 2019 |
| First Use In Commerce Date | Monday, September 30, 2019 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 8, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, September 30, 2019 |
| First Use In Commerce Date | Monday, September 30, 2019 |
| Party Name | Obsidian Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02138 |
| Event Date | Event Description |
| Saturday, May 13, 2023 | NEW APPLICATION ENTERED |
| Thursday, June 8, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 14, 2023 | ASSIGNED TO EXAMINER |
| Monday, September 18, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, September 18, 2023 | NON-FINAL ACTION E-MAILED |
| Monday, September 18, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, December 14, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Thursday, December 14, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Monday, March 18, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 18, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, March 18, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 17, 2024 | FINAL REFUSAL WRITTEN |
| Wednesday, April 17, 2024 | FINAL REFUSAL E-MAILED |
| Wednesday, April 17, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, May 23, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Thursday, May 23, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, October 17, 2024 | TEAS AMENDMENT OF USE RECEIVED |
| Thursday, October 17, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, October 17, 2024 | AMENDMENT TO USE PROCESSING COMPLETE |
| Thursday, October 17, 2024 | USE AMENDMENT FILED |
| Thursday, November 21, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, November 21, 2024 | USE AMENDMENT ACCEPTED |
| Thursday, November 21, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, November 21, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |